drugset / Trial / NCT04033107

High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors

NCT04033107

Phase 2 Unknown 30 enrolled Zhongnan Hospital
NaSingle-groupOpen-labelTreatment

Summary

This is an open, prospective, single-arm, multi-cohort clinical study to evaluate the efficacy and safety of high-dose vitamin C combined with metformin in the treatment of malignant tumors.

Timeline

Start
2020-07-01
Primary completion
2024-12
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 4 g Oral
Subject Vitamin C Other / unclassified 1.5 g/kg Intravenous